ARTICLE | Clinical News
Macrokine (WF10): Phase II trial
July 10, 2000 7:00 AM UTC
Oxo Chemie AG., Fribourg, Switzerland Product: Macrokine ( WF10) Business: Infectious diseases Therapeutic category: Immune modulation Target: Macrophages Description: Tetrachlorodecaoxygen chlorite ...